A New Glucocerebrosidase Chaperone Reduces -Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism
Elma Aflaki(National Institutes of Health), Ellen Sidransky(National Institutes of Health)
Cited by 229
Related Papers
The definition of neuronopathic Gaucher disease
|Journal of Inherited Metabolic Disease|2020|102
C16 ceramide is crucial for triacylglycerol-induced apoptosis in macrophages
|Cell Death and Disease|2012|72
Faculty Opinions recommendation of Impaired β-Glucocerebrosidase Activity and Processing in Frontotemporal Dementia Due to Progranulin Mutations
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2020|0
Immunocytochemistry with mDANs v1
|Unknown|2025|0